ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Company-funded studies of approved drugs may not catch safety issues
February 21, 2017Research results published in the BMJ suggest that post-marketing studies funded by drug companies may be too small to detect rare side effects, as reported in Yahoo!Finance. -
Piramal Enterprises to acquire portfolio of drugs Mallinckrodt
February 07, 2017The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the US, and two pain management products, which are currently under development
Pharma Sources Insight January 2025
